BR112018068466A2 - lactic acid bacteria composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, concomitant fungal infections - Google Patents
lactic acid bacteria composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, concomitant fungal infectionsInfo
- Publication number
- BR112018068466A2 BR112018068466A2 BR112018068466A BR112018068466A BR112018068466A2 BR 112018068466 A2 BR112018068466 A2 BR 112018068466A2 BR 112018068466 A BR112018068466 A BR 112018068466A BR 112018068466 A BR112018068466 A BR 112018068466A BR 112018068466 A2 BR112018068466 A2 BR 112018068466A2
- Authority
- BR
- Brazil
- Prior art keywords
- infections
- present
- composition
- lactic acid
- acid bacteria
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
a presente invenção refere-se a uma composição farmacêutica ou uma composição para um dispositivo médico ou uma composição para um suplemento alimentar (resumidamente, a(s) composição(ões) da presente invenção), com base em bactérias ácido-lácticas pertencentes à espécie lactobacillus fermentum, de uso vaginal e oral para o tratamento simultâneo de infecções, transtornos ou doenças vaginais de origem fúngica e bacteriana. especificamente, a presente invenção refere-se a uma referida composição que compreende excipientes farmacêuticos e/ou de grau alimentar e uma mistura, a qual compreende ou, alternativamente, consiste em pelo menos uma cepa de bactérias pertencentes à espécie lactobacillus fermentum, de uso vaginal e oral para o tratamento simultâneo de infecções, transtornos ou doenças vaginais selecionados a partir de candidíase, vaginite, vulvovaginite ou vaginose bacteriana.The present invention relates to a pharmaceutical composition or a medical device composition or a food supplement composition (briefly, the composition (s) of the present invention) based on lactic acid bacteria belonging to the species. lactobacillus fermentum, for vaginal and oral use for the simultaneous treatment of infections, disorders or vaginal diseases of fungal and bacterial origin. Specifically, the present invention relates to said composition comprising pharmaceutical and / or food grade excipients and a mixture which comprises or alternatively consists of at least one strain of bacteria belonging to the vaginal lactobacillus fermentum species. and oral for the simultaneous treatment of infections, disorders or vaginal diseases selected from candidiasis, vaginitis, vulvovaginitis or bacterial vaginosis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUA20162013 | 2016-03-24 | ||
PCT/IB2017/051710 WO2017163216A1 (en) | 2016-03-24 | 2017-03-24 | Lactic acid bacterial composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, of concurrent fungal infections |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112018068466A2 true BR112018068466A2 (en) | 2019-01-22 |
Family
ID=59899113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112018068466A BR112018068466A2 (en) | 2016-03-24 | 2017-03-24 | lactic acid bacteria composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, concomitant fungal infections |
Country Status (3)
Country | Link |
---|---|
BR (1) | BR112018068466A2 (en) |
CA (1) | CA3018035A1 (en) |
WO (1) | WO2017163216A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20110793A1 (en) | 2011-05-09 | 2012-11-10 | Probiotical Spa | STRAINS OF PROBIOTIC BACTERIA AND SYNBIOTIC COMPOSITION CONTAINING THEMSELVES INTENDED FOR THE BABY FOOD. |
CN110540945B (en) * | 2018-05-29 | 2023-04-25 | 广东强基药业有限公司 | Lactobacillus jensenii and application thereof in preparing vaginal antibacterial drugs |
PL241599B1 (en) | 2019-11-06 | 2022-11-07 | Sanprobi Spolka Z Ograniczona Odpowiedzialnoscia Spolka Komandytowa | New Lactobacillus fermentum PL9 strain and its application |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL210465B1 (en) * | 2007-06-04 | 2012-01-31 | Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna | Composition of strains type Lactobacillus and application of the composition of strains type Lactobacillus |
EP2158916A1 (en) * | 2008-08-27 | 2010-03-03 | Ellen Aktiebolag | Administration unit comprising lactic acid bacteria |
FI20095550A0 (en) * | 2009-05-19 | 2009-05-19 | Bayer Schering Pharma Oy | Vaginal delivery system |
IT1403661B1 (en) * | 2011-01-28 | 2013-10-31 | Probiotical Spa | EFFERVESCENT COMPOSITION IN THE SOLID FORM FOR USE IN VAGINAL APPLICATIONS FOR THE TREATMENT OF VAGINAL INFECTIONS. |
ITMI20110679A1 (en) * | 2011-04-20 | 2012-10-21 | Giovanni Mogna | COMPOSITION INCLUDING PROBIOTIC BACTERES ABLE TO RESTORE THE BARRIER EFFECT OF THE STOMACH THAT IS LOST DURING THE PHARMACOLOGICAL TREATMENT OF GASTRICITY. |
WO2013093941A2 (en) * | 2011-12-21 | 2013-06-27 | Talwar Research Foundation | Compositions comprising probiotic lactobacillus strains for improved vaginal health |
ITMI20130794A1 (en) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | COMPOSITION INCLUDING LACTIC BACTERIA FOR USE IN THE PREVENTIVE AND CURATIVE TREATMENT OF BACTERIAL VAGINOSIS. |
-
2017
- 2017-03-24 WO PCT/IB2017/051710 patent/WO2017163216A1/en active Application Filing
- 2017-03-24 CA CA3018035A patent/CA3018035A1/en not_active Abandoned
- 2017-03-24 BR BR112018068466A patent/BR112018068466A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA3018035A1 (en) | 2017-09-28 |
WO2017163216A1 (en) | 2017-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2017013231A2 (en) | Compositions comprising a bacterial strain of the genus parabacteroides | |
CO2017013287A2 (en) | Compositions comprising a bacterial strain of the genus Roseburia | |
BR112019011702A2 (en) | treating a gastrointestinal tract disease with an il-12 / il-23 inhibitor released using an ingestible device | |
BR112018015097A2 (en) | composition and reactors | |
AR106768A1 (en) | COMPOSITIONS THAT INCLUDE BACTERIAL VINTAGES | |
EA201791702A1 (en) | THERAPEUTIC TOOLS ON THE BASIS OF GLYCANS AND RELATED METHODS | |
BR112018004532A2 (en) | use of pasteurized akkermansia for the treatment of metabolic disorders | |
BR112017003419A2 (en) | stable anti-il-4r-alpha antibody formulation | |
BR112018068466A2 (en) | lactic acid bacteria composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, concomitant fungal infections | |
BR112017006416A2 (en) | nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile | |
CL2019002218A1 (en) | Triple combination formulations and methods to treat or reduce the risk of cardiovascular disease. | |
EP4233902A3 (en) | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor | |
BR112018015367A2 (en) | nanofiber oromucosal carriers for therapeutic treatment | |
BR112017018328A2 (en) | tfpi-binding antibody, method for producing and composition comprising the same | |
PE20190122A1 (en) | USE OF BACTERIAL STRAINS BELONGING TO THE LACTOBACILLUS KEFIRI SPECIES IN PEDIATRICS TO GENERATE AND / OR MAINTAIN A STATE OF HOMEOSTASIS | |
ES2524385R1 (en) | Pharmaceutical composition and its use to prepare a medicine for the treatment and prevention of HIV diseases | |
BR112017012406A2 (en) | fixed ratio formulation of insulin glargine / lixisenatide | |
BR112015029897A2 (en) | solid composition for oral administration containing ibandronic acid or a pharmaceutically acceptable salt thereof and vitamin d and process for obtaining said composition | |
BR112017022653A2 (en) | Methods for treating or preventing a disease, rheumatoid arthritis, prostatitis and bph? | |
CL2017001818A1 (en) | Lactic acid bacterium and its use for the treatment of mastitis | |
BR112018014723A2 (en) | bacterial ghosts for cancer treatment | |
BR112017019364A2 (en) | solid dispersions | |
WO2019155360A3 (en) | Pharmaceutical composition for treating bacterial and viral infections | |
BR112019010792A8 (en) | COMPOSITION COMPRISING A BACTERIAL MIXTURE FOR USE IN THE PREVENTION AND IMPROVEMENT OF THE CONDITION OF UNGULATES SUFFERING FROM DISEASES INVOLVING A PARASITIC OR BACTERIAL FOOT INFECTION. | |
CR20190466A (en) | Treatment of a bacterial vaginal infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |